Sadaghiani, Mohammad S.
Roman, Samantha
Diaz-Arias, Luisa A.
Habis, Ralph
Venkatesan, Arun
Probasco, John C. http://orcid.org/0000-0003-2095-0786
Solnes, Lilja B.
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (T32EB006351)
Article History
Received: 13 March 2023
Accepted: 14 May 2023
First Online: 2 June 2023
Declarations
:
: Drs. Sadaghiani reports no relevant disclosures. Dr. Roman has no relevant disclosures. Dr. Diaz-Arias reports no relevant disclosures. Dr. Habis reports serving as study-site coordinator for a clinical study sponsored by Genentech. Dr. Venkatesan reports no relevant disclosures. Dr. Solnes reports research funding support from Novartis, Cellectar, Precision Molecular Imaging. Royalties from Elsevier. She serves on a data safety monitoring board for Molecular Insights Pharmaceuticals. Dr. Probasco reports serving as a study-site principal investigator for a clinical study sponsored by Genentech. He also reports service as Editor-in-Chief of <i>NEJM Journal Watch Neurology</i>.
: This study was performed according to STARD 2015 guideline and was approved by the Institutional Review Board of Johns Hopkins University.
: Included patients either provided informed consent for enrollment in the Johns Hopkins Encephalitis Center prospective encephalitis and seizure disorder registry (IRB00087582) or were included with waiver of consent in the Johns Hopkins Encephalitis Center retrospective clinical database (IRB00274403).